Status:

COMPLETED

EmbracePlus, Care App and Aura Usability Study

Lead Sponsor:

Empatica, Inc.

Collaborating Sponsors:

United States Department of Defense

Conditions:

Usability

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to evaluate the usability of the system which includes the wearable device, app and cloud data processing, including an algorithm (Aura) capable of detecting possible earl...

Detailed Description

The investigators wish to evaluate of the usability, according to the requirements of IEC 62366-1:2015/AMD 1:2020 of a wearable device - EmbracePlus, the Empatica Care app and Aura algorithm, an early...

Eligibility Criteria

Inclusion

  • Age: Participants must be between the ages of 18-99
  • Gender: No restrictions
  • Disease: healthy participants
  • Adult participant must either be able to give consent
  • Participants must be fluent in the language of the consent forms (Currently limited to English).
  • Participants must reside in the United States.
  • Participants should have a physical home address where they can receive the device
  • Participants must have a personal smartphone Apple or Android (at least iPhone 8 or Android 5.0)

Exclusion

  • Participants must not have broken or injured skin at the wrist where EmbracePlus is worn, and they must be able to tolerate wearing EmbracePlus snugly for long periods of time. Thus, they should not have allergies to the material composition of the EmbracePlus smartwatch, or discomfort wearing a smartwatch during the night.
  • Participants are not willing to wear the device during nighttime
  • Participants should not have pre-existing cardiovascular disease or respiratory disease
  • Participants must not be pregnant or planning to become pregnant within two months at the time of screening

Key Trial Info

Start Date :

May 31 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 31 2022

Estimated Enrollment :

335 Patients enrolled

Trial Details

Trial ID

NCT04807608

Start Date

May 31 2021

End Date

May 31 2022

Last Update

June 2 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Empatica Inc

Boston, Massachusetts, United States, 02108